Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,473
Total Claims
$3.2M
Drug Cost
898
Beneficiaries
$3,598
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
+136%
Cost per patient vs peers
$3,598 vs $1,524 avg
+80%
Brand preference vs peers
24.6% vs 13.7% avg
Brand vs Generic
Brand: 4,783 claims · $2.9M
Generic: 14,672 claims · $317K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sacubitril/Valsartan | 1,507 | $1.2M |
| Apixaban | 1,108 | $776K |
| Dronedarone Hcl | 225 | $203K |
| Icosapent Ethyl | 445 | $184K |
| Dapagliflozin Propanediol | 94 | $72K |
| Rivaroxaban | 95 | $64K |
| Alirocumab | 110 | $59K |
| Pitavastatin Calcium | 109 | $48K |
| Empagliflozin | 70 | $46K |
| Ranolazine | 514 | $45K |
| Vericiguat | 40 | $34K |
| Metoprolol Succinate | 1,679 | $29K |
| Evolocumab | 47 | $28K |
| Rosuvastatin Calcium | 1,325 | $24K |
| Lipase/Protease/Amylase | 18 | $19K |
Prescribing Profile
Patient Profile
79
Avg Age
68%
Female
2.03
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data